InvestmentApr 16, 2026, 04:10 PM
Trevi Therapeutics Commences $150M Public Stock Offering
AI Summary
Trevi Therapeutics, Inc. announced the commencement of an underwritten public offering to sell $150,000,000 of its common stock. The company also granted underwriters a 30-day option to purchase up to an additional $22,500,000 in shares. The offering is subject to market conditions and is being made pursuant to a shelf registration statement.
Key Highlights
- Trevi Therapeutics commenced an underwritten public offering of common stock.
- Initial offering size is $150,000,000.
- Underwriters have a 30-day option to purchase an additional $22,500,000 in shares.
- Morgan Stanley, Leerink Partners, Cantor, and Stifel are joint book-running managers.